Expired Manager Biostatistics jobs in Baton Rouge, LA
Baton Rouge, LA
$98,812-$143,043/year (est.)
BeiGene continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our passionate interest in...
Baton Rouge, LA
$68,948-$144,544/year (est.)
We’re on a journey to advance how health happens with technologies that empower patients, support clinicians, inspire innovation, and save lives. Our mission? To create a human-centric healthcare experience powered by unified global data. It’s a big challenge, but big challenges are what we do...
Sumitomo Pharma
Baton Rouge, LA
$113K-$148K / yr.
Manager, Biostatistics Sumitomo Pharma America (SMPA) is focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need spanning psychiatry & neurology, oncology, urology, women’s health, rare disease, and cell & gene therapies. The company’s diverse portfolio...
Sumitomo Pharma
Baton Rouge, LA
$138K-$180K / yr.
Senior Manager, Biostatistics Sumitomo Pharma America (SMPA) is focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need spanning psychiatry & neurology, oncology, urology, women’s health, rare disease, and cell & gene therapies. The company’s diverse...
Baton Rouge, LA
$141K-$200K / yr.
Senior Manager, Biostatistics, (Remote, USA) Transcatheter Mitral & Tricuspid Therapies The Sr Manager, Biostatistics Level is lateral to Associate Director, Biostatistics ("Associate Director Biostatistics") level at Edwards Edwards' transcatheter mitral and tricuspid therapies (TMTT), and...
Loxo@Lilly
Baton Rouge, LA
$98,812-$143,043/year (est.)
Loxo@Lilly conducts discovery research, clinical development and regulatory affairs for oncology, with the goal of creating a pipeline of therapies that have the potential to make a meaningful difference for patients. Loxo@Lilly was created in December 2019, combining the Lilly Research...